Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.34 |
| ▸ | LMNA | P02545 | 2/20 | 0.34 |
| ▸ | TSHR | P16473 | 2/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | USP2 | O75604 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | PKM | P14618 | 1/20 | 0.34 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2625532 | 0.82 | KMT2A (0.37) | KMT2AALDH1A1LMNATSHRPOLB | |
| SCHEMBL329518 | 0.82 | KMT2A (0.38) | KMT2AALDH1A1LMNATSHRPOLB | |
| SCHEMBL2625534 | 0.82 | KMT2A (0.37) | KMT2AALDH1A1LMNATSHRPOLB | |
| SCHEMBL2622404 | 0.82 | KMT2A (0.37) | KMT2AALDH1A1LMNATSHRPOLB | |
| SCHEMBL12137138 | 0.78 | ALDH1A1 (0.37) | KMT2AALDH1A1LMNATSHRPOLB | |
| SCHEMBL23682596 | 0.78 | KMT2A (0.35) | KMT2AALDH1A1LMNATSHRPOLB | |
| SCHEMBL1267540 | 0.78 | KMT2A (0.39) | KMT2AALDH1A1LMNATSHRPOLB | |
| SCHEMBL19441508 | 0.77 | PKM (0.36) | KMT2AALDH1A1LMNATSHRPOLB | |
| SCHEMBL17199775 | 0.77 | ALDH1A1 (0.37) | KMT2AALDH1A1LMNATSHRPOLB | |
| SCHEMBL14527694 | 0.77 | ALDH1A1 (0.38) | KMT2AALDH1A1LMNATSHRPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11572558-B2 | Single-stranded oligonucleotide | NISSAN CHEMICAL CORPORATION (JP) | 2023-02-07 | — | — | US | disclosed |
| US-20210254055-A1 | SINGLE-STRANDED OLIGONUCLEOTIDE | NISSAN CHEMICAL CORPORATION (JP) | 2021-08-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11572558-B2 | Single-stranded oligonucleotide | MLX, ZFX, UPF1 | KMT2A 1960/4885ALDH1A1 4023/4885LMNA 102/4885 |
| US-20210254055-A1 | SINGLE-STRANDED OLIGONUCLEOTIDE | MLX, ZFX, UPF1 | KMT2A 1960/4885ALDH1A1 4023/4885LMNA 102/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.